RATIONALE
Minimally Invasive Thyroid Treatments (MITT) are increasingly applied in the clinical practice all over Europe for the treatment for benign and malignant thyroid diseases.
The MITT group has been founded in 2018 in Italy to promote multidisciplinary partnership among physicians with different expertise who share the interest in MITT and to improve the clinical, diagnostic, and therapeutic management of
benign and malignant thyroid and parathyroid glands diseases.
During the 2024 MITT meeting, the present guidelines on both benign and malignant thyroid disease management will be presented, and the most widely used techniques for ablation will be presented by renowned experts in the field.
Also, the most updated evidence on the application of MITT in benign thyroid nodules, autonomously functioning thyroid nodules, and malignant tumours will be illustrated.
Furthermore, a series of real-life clinical cases will be presented and discussed between the expert panel and the participants.
During the second day, the organization of a thyroid ablation clinical practice will be discussed, with particular focus on preoperative and postoperative patients’ management, possible type of anaesthesia, with the discussion of a video-recorded treatment.
In the end, a series of “hot topics” on minimally invasive treatments of the thyroid will be presented and discussed with the participants, including treatment of parathyroid adenomas, complications of MITT and their management, and the problem of nodule regrowth.
Hands-on workshops will also be available at the end of the meeting for those who will want to try the different available technologies and techniques on dedicated phantoms.

LOCAL HOST
Giovanni Mauri, Milan - IT
Luca Maria Sconfienza, Milan - IT
Luigi Solbiati, Milan - IT

SCIENTIFIC COMMITTEE
Stella Bernardi, Trieste - IT
Jose Luis Del Cura, Donostia, Gipuzkoa - ES
Edouard Ghanassia, Sete - FR
Mirsyni Gkeli, Athens - GR
Giovanni Mauri, Milan - IT
Hervè Monpeyssen, Paris - FR
Enrico Papini, Albano Laziale, RM - IT
Luca Maria Sconfienza, Milan - IT
Luigi Solbiati, Milan - IT
Harald Dobnig, Graz - AU
Robert M. Eisele, Bernauer -DE
Stefano Spezia, Naples – IT

OFFICIAL LANGUAGE
English

ITALIAN CME CREDITS - ID 317-406306
The Congress has been accredited at the Italian Continuing Medical Education (CME).
Nr. 5,6 credits for Physician: Endocrinology, Oncology, Radiodiagnosis, Internal Medicine, General Surgery, Pathological Anatomy, Otolaryngology, Nuclear Medicine.

REGISTRATION
The congressis is reserved for n. 200 Participants
The Hands on courses are reserved for n. 60 participants

Registration after January 15th, 2023
€ 350,00 (Vat included) exclusive registration to the congress
€ 450,00 (Vat included) registration to the congress and n. 1 Hands-on course (*)
€ 100,00 (Vat included) exclusive registration to the congress - Members of Scientific Societies affiliated:  SYT, SIUMB, AME, AFTHY, SEUS, HUNGARIA INTERNATIONAL SOCIETY, TGRD, APRI, DGE
€ 150,00 (Vat included) registration to the congress and n. 1 Hands-on course  - Members of Scientific Societies affiliated:  SYT, SIUMB, AME, AFTHY, SEUS, HUNGARIA INTERNATIONAL SOCIETY, TGRD, APRI, DGE
For Residents: free Registration exclusive to the congress

(*) REGISTRATION TO THE HANDS-ON COURSES ARE CLOSED

CONFERENCE VENUE
Auditorium - Congress Center
IRCCS Ospedale Galeazzi - Sant’Ambrogio 
Via Cristina Belgioioso 173
Milan, Italy

By Subway 
MM1 (Red Line) 
• Stop Rho Fiera, walking 1200 meters
By Train
•Stop Rho Fiera, walking 1000 meters
 

SCARICA IL PROGRAMMA